ZA888993B - Method for treatment of dyslipidemia in humans - Google Patents

Method for treatment of dyslipidemia in humans

Info

Publication number
ZA888993B
ZA888993B ZA888993A ZA888993A ZA888993B ZA 888993 B ZA888993 B ZA 888993B ZA 888993 A ZA888993 A ZA 888993A ZA 888993 A ZA888993 A ZA 888993A ZA 888993 B ZA888993 B ZA 888993B
Authority
ZA
South Africa
Prior art keywords
dyslipidemia
humans
treatment
Prior art date
Application number
ZA888993A
Other languages
English (en)
Inventor
William Darrow
Darrow William
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA888993B publication Critical patent/ZA888993B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA888993A 1987-11-30 1988-11-30 Method for treatment of dyslipidemia in humans ZA888993B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/126,441 US4788183A (en) 1987-11-30 1987-11-30 Method for treatment of dyslipidemia in humans

Publications (1)

Publication Number Publication Date
ZA888993B true ZA888993B (en) 1989-07-26

Family

ID=22424849

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA888993A ZA888993B (en) 1987-11-30 1988-11-30 Method for treatment of dyslipidemia in humans

Country Status (10)

Country Link
US (1) US4788183A (xx)
EP (2) EP0391958A1 (xx)
JP (1) JPH02503314A (xx)
KR (1) KR890701111A (xx)
AU (1) AU2816889A (xx)
DK (1) DK132090D0 (xx)
HU (1) HUT53526A (xx)
NZ (1) NZ227123A (xx)
WO (1) WO1989005146A2 (xx)
ZA (1) ZA888993B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211947A (en) * 1988-12-16 1993-05-18 Schering Corporation Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor
US6264960B1 (en) 1998-11-10 2001-07-24 Sander J. Robins Treatment of vascular events using lipid-modifying compositions
US20040072903A1 (en) * 2001-05-08 2004-04-15 Auerbach Bruce Jeffrey Carboxyalkylether-acat inhibitors combinations
WO2006020999A2 (en) * 2004-08-19 2006-02-23 The United States Of America, As Represented By The Secretary Of Agriculture Pterostilbene as a new agonist for the peroxisome proliferator-activated receptor alpha isoform

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
ZA794872B (en) * 1978-09-20 1980-11-26 Schering Corp A phenylalkylaminoethylsalicylamide,its preparation and pharmaceutical compositions containing it
US4658060A (en) * 1982-04-26 1987-04-14 Schering Corporation Preparation of (-)-5-(beta)-1-hydroxy-2-((beta)-1-methyl-3-phenylpropyl)aminoethyl) salicylamide

Also Published As

Publication number Publication date
WO1989005146A2 (en) 1989-06-15
WO1989005146A3 (en) 1989-10-19
AU2816889A (en) 1989-07-05
HU890492D0 (en) 1990-09-28
KR890701111A (ko) 1989-12-19
DK132090A (da) 1990-05-29
HUT53526A (en) 1990-11-28
NZ227123A (en) 1990-08-28
JPH0532368B2 (xx) 1993-05-14
DK132090D0 (da) 1990-05-29
US4788183A (en) 1988-11-29
EP0318889A2 (en) 1989-06-07
EP0391958A1 (en) 1990-10-17
JPH02503314A (ja) 1990-10-11
EP0318889A3 (en) 1989-11-29

Similar Documents

Publication Publication Date Title
GB8704089D0 (en) Method of treatment
ZA888993B (en) Method for treatment of dyslipidemia in humans
GB2239412B (en) Methods of treating surfaces
GB8916394D0 (en) Method of treatment
GB8704088D0 (en) Method of treatment
GB8704090D0 (en) Method of treatment
GB8718025D0 (en) Method of treatment
GB8911258D0 (en) Method of treatment
GB8929033D0 (en) Method of treatment
GB8920985D0 (en) Method of treatment
GB8912935D0 (en) Method of treatment
GB8912934D0 (en) Method of treatment
GB8928896D0 (en) Method of treatment
GB8906430D0 (en) Method of treatment
GB8906429D0 (en) Method of treatment
GB8924155D0 (en) Method of treatment
GB8906428D0 (en) Method of treatment
GB8906427D0 (en) Method of treatment
GB8906426D0 (en) Method of treatment
GB8906425D0 (en) Method of treatment
GB8906424D0 (en) Method of treatment
GB8904258D0 (en) Method of treatment
ZA904464B (en) Method of treatment using 17beta-cyclopropylaminoandrostene
GB8727093D0 (en) Treatment of baldness in humans
GB8812229D0 (en) Method of treatment